Committee on Energy and Commerce, Democrats Home Page
Who We Are Schedule What's New
View Printable Version
Home Page > The 110th Congress Public Record > By Subject > Oversight and Investigations

OVERSIGHT & INVESTIGATIONS

The Public Record for the 110th Congress

This is a list of public information regarding oversight and investigations released in the 110th Congress by the Committee on Energy and Commerce. The information is listed by date. If you require information that was available on this Web site for a previous Congress, please see the archives page.

» News Releases

» Letters

» Statements

» Reports

 

News Releases
September 8, 2008

Dingell, Stupak on Administration’s Withdrawal of Russian Nuclear Agreement

August 22, 2008

Dingell, Stupak Applaud FDA’s Approval of Irradiation on Lettuce & Spinach; After Eight Years, FDA Finally Acts on Petition to Help Prevent Foodborne Illness

August 21, 2008

Dingell, Stupak Question Drug Makers on Safety of Vytorin and Conflicting Study Data; Recent Study Links Vytorin to Increased Cancer Risk

August 11, 2008

Dingell, Stupak Ask for GAO Report on Highly Enriched Uranium

August 5, 2008

Dingell, Stupak Applaud FDA for ESA Label Change

July 28, 2008

Committee Leaders Release CRS Report Showing DOE’s Counterintelligence Program May Be Off Course

Read the CRS Report »

July 23, 2008

Senate, House Members Release Results of GAO Report on Long-Term Care Insurance

Read the GAO Report »

July 22, 2008

Dingell, Stupak to Investigate Ranbaxy Drug Approvals

July 22, 2008

Dingell, Stupak Comment on Results of New Vytorin Study

July 21, 2008

Dingell, Stupak Comment on Latest Developments in FDA Salmonella Investigation

July 17, 2008

Dingell, Stupak Question Whether FDA Knowingly Allowed Potentially Unsafe & Ineffective Drugs into the U.S. Marketplace

Read the Motion »

July 15, 2008

GAO Report Finds Los Alamos Security Problems Still Not Fully Addressed

Read the GAO Report »

July 9, 2008

Dingell, Stupak Comment on Beef Recall

July 2, 2008

Dingell, Stupak Continue Food Safety Investigation as FDA Struggles to Pinpoint Source of Salmonella Outbreak

June 26, 2008

Dingell on FDA Bonuses

June 25, 2008

Lawmakers Call for GAO Probe of Security at Lawrence Livermore Nuclear Lab

June 16, 2008

Dingell, Stupak Welcome PhRMA Invitation to Discuss DTC Regulations

June 10, 2008

Dingell on Administration’s Budget Request for FDA

June 5, 2008

Committee to Hold Legislative Hearings on Climate Change Proposals

May 23, 2008

Committee Questions Homeland Security Plans to Move Animal Disease Research Facility to U.S. Mainland

May 23, 2008

Dingell, Stupak Request GAO Probe State Department’s Assessment of Russian Nuclear Pact

May 22, 2008

Government Accountability Office Report Raises Red Flags on DOE Nuclear Waste Reprocessing Program

May 20, 2008

Dingell, Stupak Request Improved Accuracy, Stronger Guidelines for DTC Ads

May 15, 2008

Committee Probes Nursing Home Quality Issues

May 14, 2008

Dingell on Russian Nuclear Pact Being Sent to Congress

May 8, 2008

Dingell, Stupak ask Multinational Food Processors about Contamination

May 7, 2008

Dingell, Stupak to President: Address Proliferation Concerns before Sending Russian Nuclear Pact to Congress

May 6 , 2008

Dingell, Stupak Call on Infant Formula Manufacturers to Remove Bisphenol A from Packaging

read the letters »

May 6 , 2008

Dingell, Stupak Move to Expose Purveyors of Adulterated Food

read the letters »

April 30, 2008

Dingell, Stupak on Public Comment Draft of CDC Great Lakes Report

April 22, 2008

Dingell, Stupak Respond to FDA’s Announcement on Heparin

April 18, 2008

Dingell, Stupak Praise Nalgene and Wal-Mart Canada for Discontinuing Use of Bisphenol A

April 17, 2008

Energy and Commerce Committee Seeks Probe of Hanford Nuclear Waste Site

April 11, 2008

After Review of ENHANCE Trial Documents, Dingell, Stupak Express “Serious Concerns”

Read the Letter »
Read the Attachments »

April 8, 2008

Committee Probe Finds FDA Used Industry Studies to Approve Chemical in Infant Formula Liners

read the letter »

April 2, 2008

Dingell, Stupak Investigate American Chemistry Council, EPA Review Panels

read the letter »

April 1, 2008

Dingell, Stupak Continue Investigations into DTC Advertising and ESA Safety

read the letter to Johnson & Johnson »
read the letter to Amgen »

April 1, 2008

Jump in Uranium Prices Provides $7.6 billion potential windfall to Energy Department

read the report »

March 27, 2008

Dingell, Stupak Move to Protect Great Lakes Report Whistleblower

read the letter »

March 24, 2008

Committee to Probe Breakdowns in NIH Security

March 19, 2008

Committee Panel to Hold Hearings on Heparin Failures

read the letter »

March 13, 2008

Dingell on Release of CDC Great Lakes Report

March 11, 2008

Dingell, Stupak Continue ‘Science for Sale’ Probe Request Consulting Firm Case Studies

March 7, 2008

Committee Leaders Commend New Commerce IG for Restoring Whistleblower Jobs

read the letter »

March 5, 2008

Energy and Commerce Committee Subpoenas Hallmark/Westland Chief

February 28, 2008

Energy and Commerce Leaders Investigate Cover-Up of Great Lakes Report

read the Report »
read the Letter »

February 25, 2008

How Much Will it Cost to Adequately Fund FDA’s Core Programs? Energy & Commerce Leaders Release Recommendations of Former Members and Advisors to FDA’s Science Advisory Board

February 25, 2008

Dingell, Stupak Comment on Pfizer Decision to Pull Lipitor Ads Featuring Dr. Jarvik

February 21, 2008

Dingell, Stupak Consider Changing Law Over Heparin Failures

Read the Letters:

Letter to FDA Commissioner von Eschenbach »
Letter to HHS Secretary Leavitt »
Letter to Baxter International Inc. »

February 7, 2008

Committee Continues Investigation into Celebrity Drug Endorsements

February 6, 2008

Department of Energy Program Funds Russian Nuclear Work in Iran

February 6, 2008

Congressional Bisphenol A Probe Widens to
Examine Consulting Group

February 5, 2008

Dingell, Stupak Comment on FDA Revitalization Plan

January 31, 2008

Dingell, Stupak Comment on FDA Decision to Retain Field Labs

January 29, 2008

Energy and Commerce Subcommittee Subpoenas FDA Witnesses, Documents

January 25, 2008

Dingell, Stupak Comment on FDA Plan for Overseas Inspections

January 24, 2008

Dingell, Stupak Question Merck/Schering-Plough’s Sponsorship of American College of Cardiology and American Heart Association

January 23, 2008

Dingell, Stupak Comment on Decision to Pull Vytorin Ads

January 22, 2008

Dingell, Stupak Continue ENHANCE Trial Inquiry

January 17, 2008

Committee to Investigate Chemical in Infant Formula Liners

read the Letters »

January 16, 2008

Dingell, Stupak Raise Concerns, Questions on
ENHANCE Trial

January 11, 2008

Thompson Releases Report on Russian WMD Scientists

GAO report »

January 9, 2008

GAO Calls for Added Port Security with Projected Growth in Liquified Natural Gas Imports

January 7, 2008

Energy and Commerce Committee to Probe Breakdowns in NRC Oversight

December 20, 2007

Dingell, Stupak Applaud Grassley’s Ketek Investigation,Announce Additional Hearings

December 13, 2007

Dingell, Stupak Investigating Institutional Review Boards, Questionable Medical Devices

December 12, 2007

House Energy and Commerce Committee Holds Hearing on Energy Market Manipulation

December 7, 2007

Dingell, Stupak Question EPA on “Fishbowl” Transparency Policy

December 3, 2007

Dingell Announces Inquiry by Subcommittee on Oversight and Investigations into Transparency of FCC Regulatory Process

November 9, 2007

5 Years Later, White House Still Hasn’t Implemented Law to Protect Americans Near Nuclear Plants; House Energy and Commerce Committee Announces Investigation

November 2, 2007

Dingell, Stupak Request Information, Urge Agencies to Address Weaknesses with Radiation Detection Equipment

October 25, 2007

Dingell, Stupak Respond to DOJ’s Announcement of Record Penalties Against BP

October 25, 2007

Dingell, Stupak Assert that FDA Letter to Sanofi-Aventis Vindicates Whistleblowers; “Warning Letter” Shows FDA Knew Ketek Safety Study Was Compromised

October 24, 2007

Dingell, Stupak Respond to BP Price-Fixing Settlement

October 16, 2007

Dingell, Stupak Praise Giant, Stop & Shop for Ceasing Sale of Meat Treated with Carbon Monoxide

October 10, 2007

Subcommittee on Telecommunications and the Internet Approves 911 Safety, Broadband Mapping Legislation; Bills to Ensure 911 Access for VoIP Providers, Obtain Accurate Data on Nationwide Broadband Availability

October 4, 2007

Dingell, Stupak Release Report on Safety of Food Imported from China; Announce Series of Hearings

view the Report »

October 3, 2007

Committee Requests CDC Records on the Use of Antibiotics in Animals

October 2, 2007

Committee Opens Investigation into Warrantless Wiretapping; Dingell, Markey, Stupak Request Information from Phone Companies,Consumer Privacy Advocate Groups

October 2, 2007

Stupak, Dingell Applaud Energy Department Decision to Reject $9.5 billion Sole Source Contract Proposal from Energy Solutions and USEC

September 20, 2007 DOE letter »

September 21, 2007

Dingell, Stupak Announce Date for Hearing on Biosafety Labs; Recent Incidents Underscore Risks Associated with Labs

September 20, 2007

Dingell Introduces H.R. 3610, the “Food and Drug Import Safety Act of 2007”

September 18, 2007

Dingell on Grocery Manufacturers Association Food Safety Action Plan

September 18, 2007

Committee Assails Administration Plans to Certify New Radiation Portal Monitors Before Machines are Adequately Tested

September 10, 2007

Dingell Responds to Import Safety Report

September 4, 2007

Dingell, Stupak Applaud NRC for Eliminating Blanket Secrecy Policy at NRC-licensed Fuel Cycle Plants

August 24, 2007

Dingell, Stupak Question FDA Plan to Outsource Jobs

August 22, 2007

Dingell, Stupak, Melancon Welcome Announcement of New Orleans VA Hospital Reconstruction Site

August 17, 2007

Dingell, Stupak Respond to FDA Decision to Halt Lab Closings

August 13, 2007

Dingell, Stupak Praise Tyson Foods for Ceasing Sale of Meat Treated with Carbon Monoxide

August 9, 2007

Dingell, Stupak Announce Hearing on Biosafety Labs; Committee to Examine Risks Associated with Labs

August 7, 2007

Dingell, Stupak Question Appointment of Commerce Department Acting Inspector General

August 3, 2007

Dingell Releases Draft Legislation to Improve Safety of Imported Food and Drugs

July 26, 2007

Dingell Salutes First FERC Case Using New Anti-Manipulation Authority

July 25, 2007

Dingell, Stupak Respond to Attempted Retaliation Against Congressional Witnesses by Food and Drug Administration Official

July 17, 2007

Dingell, Stupak Praise Safeway, Inc. for Ceasing Sale of Meat Treated with Carbon Monoxide

June 29, 2007

Dingell, Stupak Welcome New DOE Disclosure Policy

June 29, 2007

Dingell, Stupak Commend Increase of FDA Chinese Seafood Inspection, Demand Greater FDA Accountability in Protecting American Food Supply

June 28, 2007

Dingell, Stupak Question FDA Lab Closings

June 26, 2007

Dingell, Stupak Open Investigation into Safety of Meat Treated with Carbon Monoxide; Demand Answers from Safeway, Meat Packers

June 8, 2007

Dingell, Stupak Respond to Frazier Resignation

May 24, 2007

Dingell, Stupak Not Satisfied With FDA Response to Committee Requests; Will Consider Other Options to Fulfill Requests

May 24, 2007

Committee Launches Investigation into Long Term Care Insurance

Read the letters from Dingell and Stupak to Conseco, Inc. and Penn Treaty American Corp.

May 21, 2007

Dingell, Stupak Question FDA & Glaxo for Failing to Warn Diabetics of Dangers of Avandia

May 2, 2007

BP Withheld Key Documents from Committee; Thursday Hearing Postponed to May 16

read the letter »

May 2, 2007

Committee Opens Investigation into Allegations Of Misconduct by Commerce IG

April 30, 2007

Contamination of Chinese Wheat Gluten Widespread Dingell, Stupak Dispatch Investigators to West Coast Ports

April 17, 2007

Subcommittee on Oversight and Investigations Will Hold Hearing on Mismanagement at Los Alamos National Labs

April 11, 2007

Committee Asks HHS to Study Doctors' Long Work Hours, Medical Errors

read the letter »

April 2, 2007

GAO Warns that Efforts to Protect Nuclear Materials in Russia Must Be Sustained

read the GAO Report »

March 30, 2007

HHS Inspector General to Reopen NIH Conflict-of-Interest Cases

read letter from the HHS Inspector General »

March 22, 2007

Committee Releases Leavitt Response to Concerns About Health Care Crisis in New Orleans

read response from HHS Secretary Leavitt »

March 21, 2007

Dingell, Stupak Call on Amgen, Johnson & Johnson to Suspend Direct-to-Consumer Marketing for Anemia Drugs

read the letter to Amgen Inc. »
read the letter to Johnson & Johnson »

March 20, 2007

CSB, Baker Commission Reports Confirm BP Cost-Cutting Jeopardized Worker Safety; Dingell to Hold Hearings on BP Lessons Learned Following Prudhoe Bay Spill, Field Shut Down, Recent Reports

March 14, 2007

"GAO Report Highlights Incomplete Research by Government on the Risk from Attacks on LNG Tankers; Dingell and Barton Announce Hearings on LNG Tanker Security Safety and Licensing"

read the GAO Report »

January 22, 2007

"Energy and Commerce Requests Information from FDA on Contract"

read Letter to Food and Drug Administration »

January 22, 2007

Panel Seeks Answers on Nuclear, Cyber Security; Letters to Homeland Security Department, GAO

read Letter to Government Accountability Office »
read Letter to Department of Homeland Security »

 

Letters

September 12, 2008

Letter to Wyeth on Multivitamin that Claims to lower cholesterol pdf file

September 2, 2008

Letter to Schering-Plough and Merck on Vytorin-Cancer Link pdf file

Read the Report on the Simvastatin and
Ezetimibe in Aortic Stenosis (SEAS) Study »

August 21, 2008

Letter to HHS Secretary Leavitt regarding opposition to HHS approving Rhode Island Medicaid Waiver pdf file

August 21, 2008

Letter to companies Schering-Plough and Merck & Company regarding the safety of Vytorin and Conflicting Study Data pdf file

August 8, 2008

Letter to GAO Acting Comptroller General Gene Dodaro on Highly Enriched Uranium (HEU) stockpiles around the world pdf file

July 31, 2008

Letter to the head of Wyeth Pharmaceuticals regarding a clinical trial being conducted in Ghana to test whether moxidectin can inhibit the production of the parasite associated with river blindness pdf file

July 22, 2008

Letter to FDA Commissioner von Eschenbach in regard to drugs sold in the U.S. by Ranbaxy, Inc. pdf file

June 25, 2008

Letter to U.S. Government Accountability Office Acting Comptroller General Dodaro regarding Security at Lawrence Livermore Nuclear Lab pdf file

June 17, 2008

Letter to the Commodity Futures Trading Commission regarding energy speculation pdf file

June 4, 2008

Letter to Energy Northwest Chief Executive Officer Parrish in regard to the re-enrichment of the Department of Energy's depleted uranium tails pdf file

May 22, 2008

Letter to U.S. government Accountability Office Acting Comptroller General Dodaro regarding a proposed Agreement for Cooperation for the review requirements under Section 123 of the Atomic Energy Act of 1954 pdf file

Attachment »

May 20, 2008

Letter to the CEOs of five companies regarding direct-to-consumer advertising pdf file

Johnson & Johnson »
Merck & Co., Inc. »
Pfizer, Inc. »
PhRMA »
Schering-Plough Corporation »

May 8, 2008

Letter to 49 Multinational Food Processors about Contamination pdf file

Read Recall List »

May 7, 2008

Letter to President Bush: Address Proliferation Concerns before Sending Russian Nuclear Pact to Congresspdf file

May 6, 2008

Letter to four companies requesting voluntary removal of Bisphenol A in products intended for use by infants and children pdf file

 

May 1, 2008

Letter to the presidents and CEOs of 10 private laboratories regarding to the role of the these labs in ensuring the safety of our Nation's food supply pdf file

 

April 30, 2008

Letter to the U.S. Government Accountability Office regarding the cost implications of work stoppages at the Hanford Waste Treatment Plant and Tank Farms pdf file

 

April 30, 2008

Letter to Malt-O-Meal Company President and CEO Neugent in regard to the recall of its cereal due to the risk of potential Salmonella poisoning pdf file

 

April 30, 2008

Letter to FDA Commissioner von Eschenbach in regard to the recent outbreak of Salmonella associated with cantaloupe from Honduras pdf file

 

April 29, 2008

Letter to the Committee on Agriculture Chairman Peterson and Ranking Member Goodlatte on Farm Bill Provision to Relocate Plum Island, N.Y., Laboratory to the Mainland pdf file

 

April 24, 2008

Letter to the Department of Energy regarding impartiality issues pdf file

 

April 15, 2008

Letter to the Administrator of the U.S. Agency for International Development (USAID) and the Dean of the Johns Hopkins Bloomberg School of Public Health regarding the restriction of scientific inquiry in the Population Information Online (POPLINE) database pdf file

Letter to USAID »
Letter to Johns Hopkins University »

April 11, 2008

Letter to the CEOs of Schering-Plough Corporation and Merck & Co, Inc., requesting additional information about the ENHANCE study trial pdf file

Read the Attachments »

April 4, 2008

Letter to Food and Drug Administration Commissioner von Eschenbach requesting information regarding the use of Bisphenol A in consumer products pdf file

April 2, 2008

Letter to American Chemistry Council President and CEO Gerard in regard to the use of consulting firms to manipulate public opinion related to the use of Bisphenol A and other chemicals pdf file

March 27, 2008

Letter to CDC Director Gerberding regarding the treatment of "whistleblower" employees involved in the Great Lakes Report and other studies pdf file

March 26, 2008

Letters to the U.S. Government Printing Office in regard to the distribution of our Nation's new e-Passports  pdf file

read the letter to Inspector General Ogden »
read the letter to Public Printer Tapella »

March 12, 2008

Letter to Attorney General Mukasey in regard to the plea agreement reached with British Petroleum (BP) pdf file

March 12, 2008

Letter to FCC Chairman Martin requesting further information about the management practices at the Agency pdf file

March 11, 2008

Letter to Homeland Security Secretary Chertoff requesting public release of the Homeland Security Institute's review of Advanced Spectroscopic Portal monitor development pdf file

March 6, 2008

Letter to William Nelson requesting further information regarding his e-mail sent to the Committee, his EPFX biofeedback device, and the Eclosion company pdf file

March 5, 2008

Letter to HHS Secretary Leavitt in regard to the Agency's offer to access records related to Dr. von Eschenbach's testimony before the Committee March 22, 2007 pdf file

March 1, 2008

Letter to EPA Administrator Johnson in regard to industry's use of Bisphenol A pdf file

February 28, 2008

Chairmen Dingell and Stupak write CDC Director Gerberding in regard to the withholding of a study entitled Public Health Implications of Hazardous Substances in the Twenty-Six U.S. Great Lakes Areas of Concern pdf file

February 27, 2008

Letter to HHS Secretary Leavitt in regard to the Committee's subpoena of hearing documents used to brief Dr. Andrew von Eschenbach pdf file

February 21, 2008

Letter to Homeland Security Secretary Chertoff in regard to the Agency's plans to close and relocate operations at the Plum Island Animal Disease Center pdf file

February 21, 2008

Letter to FDA Commissioner von Eschenbach requesting documents and information relating to the FDA's foreign inspection program and the drug Heparin pdf file

February 21, 2008

Letter to HHS Secretary Leavitt requesting documents and information relating to the FDA's foreign inspection program and the drug Heparin pdf file

February 21, 2008

Letter to Baxter International Inc. requesting documents and information relating to the FDA's foreign inspection program and the drug Heparin pdf file

February 14, 2008

Letter to FDA Commissioner von Eschenbach in regard to a Chinese facility which produces a drug that has been associated with hundreds of adverse events pdf file

April 24, 2008 response »

February 11, 2008

Letter to FDA Commissioner von Eschenbach requesting information that relates to the Agency's protocal approval for the ENHANCE clinical trial pdf file

February 11, 2008

Letter to Schering-Plough Corporation and Merck and Co., Inc. requesting additional information from a prior information request regarding the ENHANCE clinical trial pdf file

February 11, 2008

Letters to four companies regarding the withholding of clinical trial data during the ENHANCE trial pdf file

Letter to Softlayer Technologies, Inc. and Cafepharma Inc. »
Letter to Schering-Plough Corporation
and Merck and Co., Inc. »

February 6, 2008

Letter to Energy Secretary Bodman concerning Department of Energy funding of Russian institutes which are also providing support to the Buhsher nuclear power plant in Iranpdf file

read Russian power point slides
(referenced in the letter)
Attachment 1 »
Attachment 2 »

February 5, 2008

Letter to The Weinberg Group CEO Weinberg in regard to an ongoing investigation into the use of the chemical Bisphenol A in products intended for use by children pdf file

January 24, 2008

Letter to Schering-Plough Corporation and Merck & Co., Inc. in regard to the witholding of clinical data during the ENHANCE trial pdf file

January 24, 2008

Letter to American College of Cardiology CEO Lewin in regard to the witholding of clinical data during the ENHANCE trial pdf file

January 24, 2008

Letter to American Heart Association CEO Wheeler in regard to the witholding of clinical data during the ENHANCE trial pdf file

January 22, 2008

Letter to Health and Human Services in regard to the Committee's ongoing investigation into Vytorin and the ENHANCE trial pdf file

January 22, 2008

Letter to Schering-Plough Corporation and Merck and Co., Inc. in regard to the Committee's ongoing investigation into Vytorin and the ENHANCE trial pdf file

January 18, 2008

Letter to Soma Beverage Company, LLC President and CEO Lowe in regard to the recent recall of Metromint bottled water pdf file

January 16, 2008

Letter to GAO Comptroller General Walker requesting more information on a possible third class of "Behind-the-Counter" drugs pdf file

January 16, 2008

Letter to Schering-Plough Corporation and Merck and Co., Inc. in regard to concerns about misleading stataments in Direct-to-Consumer advertisements of prescription drugs pdf file

January 16, 2008

Letter to FDA Commissioner von Eschenbach in regard to concerns about misleading statements in Direct-to-Consumer advertisements of prescription drugs pdf file

January 7, 2008

Letter to CEO and Chairman of the Board Kindler of Pfizer, Inc., in regard to Dr. Robert Jarvik's endorsement of the drug Lipitor pdf file

read the February 25, 2008 response »

December 13, 2007

Letter to the Texas Applied Biomedical Services and the Biomedical Research Institute of America in regard to the potential misuse of Institutional Review Boards to conduct biomedical research pdf file

December 13, 2007

Letter to FDA Commissioner von Eschenbach in regard to the potential misuse of Institutional Review Boards to conduct biomedical research pdf file

December 11, 2007

Letter to Schering-Plough Corporation and Merck & Co., Inc. in regard to the witholding of clinical trial data pdf file

December 5, 2007

Letter to EPA Administrator Johnson in regard to concerns about the transparency and openness of the Agency's business pdf file

November 9, 2007

Letter to HHS Inspector General Levinson in regard to an investigation of several ethics violations at the FDA pdf file

November 9, 2007

Letter to Office of Management and Budget Director Nussle in regard to implementation of a law to protect Americans living near nuclear plants pdf file

November 2, 2007

Letter to staff at the Department of Homeland Security in regard to the deployment of the Advanced Spectroscopic Portals pdf file

October 23, 2007

Letter to the directors of the National Institutes of Health and the National Cancer Institute in regard to potential conflicts of interest that could damage the reputations of the organizations   pdf file

October 15, 2007

Chairman Stupak and Ranking Member Whitfield write OMB Director Nussle in regard to the National All Schedules Prescription Electronic Reporting Act (NASPER)   pdf file

October 12, 2007

Letter to FDA Commissioner von Eschenbach in regard to observations from a Committee staff trip to India and China  pdf file

October 11, 2007

Letter to EPA Administrator Johnson in regard to a recent Washington Post article which highlights the Administration's failure to initiate criminal prosecutions when they are merited   pdf file

October 4, 2007

Letter to GAO Comptroller General Walker in regard to an investigation of the efficiency and effectiveness of the Government agencies within the Committee's jurisdiction   pdf file

October 1, 2007

Letter to Centers for Disease Control and Prevention Director Gerberding regarding the Oversight Subcommittee's investigation into the human health consequences of antimicrobials administered to food animals  pdf file

Sept. 21, 2007

Letter urging Homeland Security Secretary Chertoff to delay certification of Advanced Spectroscopic Portals   pdf file

Sept. 20, 2007

Letter to Homeland Security Secretary Chertoff in regard to an investigation of operations at the Plum Island Animal Disease Center   pdf file

Sept. 20, 2007

Letter to Department of Agriculture Acting Secretary Conner in regard to an investigation of operations at the Plum Island Animal Disease Center   pdf file

Aug. 24, 2007

Letter to FDA Commissioner von Eschenbach in regard to the agency's plans to outsource hundreds of FDA jobs to private companies pdf file

Aug. 13, 2007

Letter to HHS Secretary Leavitt in regard the agency's cooperation for a GAO evaluation of security at biosafety laboratories pdf file

Aug. 13, 2007

Letter to Robert's American Gourmet Food, Inc. in regard to Salmonella contamination in Veggie Booty snack food pdf file

Aug. 13, 2007

Letter to Naval Inspector General Route in regard to contracting issues related to the Office of Naval Research pdf file

Aug. 13, 2007

Letter to Total Nonstop Action Wrestling President Carter in regard to illegal steroid use in pro wrestling pdf file

Aug. 13, 2007

Letter to FDA Commissioner von Eschenbach in regard to an FDA investigation of the Cordis Corporation's Coronary Stent pdf file

Aug. 10, 2007

Letter to Homeland Security Under Secretary for Management Paul Schneider in regard to the Department's ability to prevent nuclear attacks pdf file

Read the August 20, 2007 letter »

Aug. 7, 2007

Letter to Homeland Security Secretary Chertoff in regard to the adequacy of that Department's biosurveillance efforts pdf file

Aug. 7, 2007

Letter to Department of Commerce Secretary Gutierrez in regard to the Appointment of Commerce Department Acting Inspector General pdf file

Aug. 2, 2007

Letter to American Superconductor Corporation President and CEO, Yurek in regard to a contract awarded to the AMSC by the Department of Homeland Security pdf file

Aug. 2, 2007

Letter to Richard Blum, University of California Chairman of the Regents, in regard to the University's request to DOE to consider that the Eleventh Amendment bars Federal Government enforcement action due to immunity from lawsuits pdf file

Aug. 1, 2007

Letter to GAO Comptroller General David Walker in regard to the FDA's ability to ensure the safety of the Nation's drug supply pdf file

Aug. 1, 2007

Letter to DOE Secretary Bodman in regard to a $9.5 billion non-competitive decontamination contract proposal pdf file

July 31, 2007

Letter to FDA Commissioner von Eschenbach with concerns about the consequences of FDA contracting out surveillance sampling, as well as other FDA food sampling, to private laboratories pdf file

July 25, 2007

Letter to FDA Commissioner von Eschenbach in regard to retaliation against FDA witnesses pdf file

Read July 19, 2007 e-mail »

July 13, 2007

Letter to EPA Administrator Johnson in regard to the ongoing investigation of the drinking water contamination at Camp Lejeune pdf file

July 13, 2007

Letter to EPA Administrator Johnson in regard to the adequacy of the criminal enforcement program pdf file

July 6, 2007

Letter to Homeland Security Secretary Chertoff in regard to contracts awarded to American Superconductor Corporation and Consolidated Edison Group pdf file

July 6, 2007

Letter to Department of Navy Assistant Secretary of the Navy for Research, Etter in regard to a Committee evaluation of the contracts awarded to the American Superconductor Corporation pdf file

July 3, 2007

Letter to U.S. Nuclear Regulatory Commission Chairman Klein in regard to a major nuclear safety event and the release of documents relating to the event pdf file

read the June 7, 2007 NRC letter »

June 26, 2007

Letter to Department of Energy Secretary Bodman requesting documents in regard to the Radiological and Environmental Sciences Laboratory in Idaho pdf file

June 26, 2007

Letter to Tyson Foods, Inc. in regard to the safety of meat treated with carbon dioxide pdf file

read the August 9, 2007 response »

June 26, 2007

Letter to Safeway, Inc. in regard to the safety of meat treated with carbon dioxide pdf file

Ready July 16, 2007 letter from Safeway, Inc. »

June 26, 2007

Letter to Pactiv Corporation in regard to the safety of meat treated with carbon dioxide pdf file

June 26, 2007

Letter to Hormel Foods Corporation and Cargill Incorporated in regard to the safety of meat treated with carbon dioxide pdf file

June 15, 2007

Letter to FDA Commissioner von Eschenbach in regard to proposed closure of FDA laboratories pdf file

June 15, 2007

Letter to HHS Secretary Leavitt in regard to risks associated with certain prescription drugs known as EPO products pdf file

read the September 27, 2007 response »

June 14, 2007

Letter to Department of Energy Secretary Bodman in regard to a recent security incident at the Los Alamos National Laboratory (LANL) pdf file

June 6, 2007

Letter to Under Secretary for Food Safety Raymond in regard to the safety of food imports from China pdf file

June 6, 2007

Letter to FDA Commissioner von Eschenbach in regard to FDA consultant Douglas Arbesfeld's critique of an Avandia study published by Dr. Steven Nissen pdf file

read the June 7, 2007 letter from
Senate and House members »

June 5, 2007

Letter to FDA Commissioner von Eschenbach in regard to the FDA's ability to protect the safety of the Nation's food supply pdf file

May 24, 2007

Letter to HHS Secretary Leavitt in regard to problems associated with the operation of the FDA pdf file

May 23, 2007

Letter to the GAO comptroller general asking him to review matters relating to a legislative proposal by USEC Inc., to transfer uranium inventories from DOE to the corporation pdf file

May 11, 2007

Letter to BP America Chairman and President Malone in regard to the ongoing investigation of the leak incidents on the Prudhoe Bay Oil Transit Lines

May 4, 2007

Letter to FDA Commissioner von Eschenbach in regard to the safety of Avandia

April 30, 2007

Letter to FDA Commissioner von Eschenbach in regard to an investigation into post-marketing drug safety

April 30, 2007

Letter BP Chairman and President Malone, in regard to the pending investigation of the cost-cutting atmosphere at BP's Prudhoe Bay facility

April 18, 2007

Letter to FDA Commissioner von Eschenbach in regard to the FDA's ability to protect human and farm animal health from the risks associated with prescription drugs

April 13, 2007

Letter to EPA Administrator Johnson in regard to an inquiry into EPA expenditures for the Performance Track program

April 12, 2007

Letter to FCC Chairman Martin in regard to the Committee's investigation into the Universal Service Fund

April 12, 2007

Letter to GAO Comptroller General Walker in regard to an inquiry into the FCC's management of the Universal Service Fund

April 10, 2007

Letter to US Consumer Product Safety Commission Acting Chairman Nord requesting action to improve the safety of free-standing kitchen ranges

April 3, 2007

Letter to DOE Secretary Bodman requesting documents for an evaluation of the Radiological and Environmental Sciences Laboratory

March 30, 2007

Letter to FDA Commissioner Andrew von Eschenbach requesting documents for an investigation into the recent contamination of pet food

March 29, 2007

Letter to HHS Acting Director Munier in regard to continued cooperation and assistance into preventable medical errors associated with caregiver work schedules

read the response

March 28, 2007

Letter to Secretary Leavitt in regard to Commissioner Andrew von Eschenbach's appearance before the Subcommittee on Oversight and Investigations on March 22, 2007

March 27, 2007

Letter to Senators Bingaman, Domenici, Dorgan and Udall regarding the GAO's investigation of Los Alamos National Laboratory

March 20, 2007

Letter to Amgen in which Chairmen Dingell and Stupak call on the company to suspend direct-to-consumer marketing for anemia drugs pdf file

read the April 18, 2007 response »

March 20, 2007

Letter to Johnson & Johnson in which Chairmen Dingell and Stupak call on the company to suspend direct-to-consumer marketing for anemia drugs pdf file

read theApril 18, 2007 response »
read the August 10, 2007 response »

March 9, 2007

Letter to Sanofi-Aventis chairman Timothy Rothwell regarding the the circumstances surrounding the FDA approval of the Sanofi-Aventis antibiotic Ketek pdf file

March 8, 2007

Letter to HHS Secretary Leavitt regarding investigation into allegations of apparent conflicts of interest in the Food and Drug Administration contracting practices involving the former Director of the Office of Information Technology

March 6, 2007

Letter to ConAgra Foods, Inc., regarding the Committee's investigation into the safety of the Nation's food supply and the recent outbreak of salmonella contamination in peanut butter produced by ConAgra

March 5, 2007

Letter to Acting Chairman Nancy A. Nord, Consumer Product Safety Commission, regarding the stability of free-standing kitchen ranges sold and installed in the U.S., including repots that serious injuries and even deaths may have been caused by kitchen ranges tipping over onto small children

February 28, 2007

Letter to Department of Homeland Security Secretary Chertoff regarding the Committee's investigation into illegal activity over the Internet

February 27, 2007

Letter to Treasury Secretary Paulson regarding the Committee's inquiry into illegal activity over the Internet

February 27, 2007

Letters to Platinum Solutions, Inc. and ProObject, Inc. regarding the Committee's investigation of possible conflicts of interest in contracting at the U.S. Food and Drug Administration

read the Letter to Platinum Solutions »
read the Letter to ProObject, Inc. »

February 27, 2007

Letters to Copernicus Group, IRB and PPD, Inc., regarding the Committee's inquiry into the adequacy of the efforts of the U.S. FDA to protect the American public from excessive risks from prescription drugs, including the circumstances surrounding the Sanofi-Aventis antibiotic Ketek

read the Letter to Copernicus Group, IRB »
read the Letter to PPD, Incorporated »

February 16, 2007

Letter to U.S. Comptroller General Walker requesting the assistance of GAO in developing and implementing options to solve the problems, including security failures, at the Los Alamos National Laboratory

February 16, 2007

Letter to HHS Secretary Leavitt requesting documents and information related to the Committee's investigation of pre-market review and post-market surveillance of the antibiotic telithromycin (Ketek)

February 15, 2007

Letter to FDA Commissioner von Eschenbach regarding the recent major outbreak in the United States of salmonella in peanut butter

February 6, 2007

Letter to FDA Commissioner von Eschenbach regarding FDA contemplating a shut down of 7 to 9 of the 13 laboratories that the FDA operates, including the Forensic Chemistry Lab

February 5, 2007

Letter to HHS Secretary Leavitt regarding HHS's newly-announced plan to improve the healthcare delivery system in the Gulf Region affected by Hurricane Katrina

January 29, 2007

Letter to FDA Commissioner von Eschenbach regarding the Committee's investigation into the adequacy of the efforts of the FDA to protect the safety of the Nation's food supply

January 29, 2007

Letter to FDA Commissioner von Eschenbach regarding the Committee's inquiry regarding the adequacy of the generic drug approval process at the FDA

January 19, 2007

Letter to the Department of Homeland Security's Director of the Domestic Nuclear Detection Office asking for information regarding the efforts of the DNDO to test and deploy nuclear detection technologies

January 19, 2007

Letter to Comptroller General Walker requesting a review of the Department of Energy's cyber security programs and provide a report

January 19, 2007

Letter to SEC Chairman Cox regarding the ongoing Hewlett-Packard investigation and H-P CEO Hurd's insider-trading response

 

Statements

July 31, 2008

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, “The Recent Salmonella Outbreak: Lessons Learned and Consequences to Industry and Public Health.”

July 24, 2008

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, “Long-Term Care Insurance: Are Consumers Protected for the Long Term?”

June 23, 2008

Chairman Dingell at the Subcommittee on Oversight and Investigations Subcommittee hearing entitled, “Energy Speculation: Is Greater Regulation Necessary to Stop Price Manipulation? – Part II”

June 12, 2008

Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing entitled, “American Lives Still at Risk: When Will FDA’s Food Protection Plan Be Fully Funded and Implemented?”

May 29, 2008

Dingell, Stupak on CFTC Energy Futures Trading Proposal

May 22, 2008

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, "Germs, Viruses and Secrets: Government Plans to Move Exotic Disease Research to the Mainland United States"

May 15 , 2008

Chairman Dingell, Subcommittee on Oversight and Investigations Hearing entitled "In the Hands of Strangers: Are Nursing Home Safeguards Working?”

May 8 , 2008

Chairman Dingell, Subcommittee on Oversight and Investigations Hearing entitled, "Direct-to-Consumer Advertising: Marketing, Education or Deception?”

April 29, 2008

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, "The Heparin Disaster: Chinese Counterfeits and American Failures"

April 22, 2008

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, "FDA’s Foreign Drug Inspection Program: Weaknesses Place Americans at Risk"

April 3, 2008

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, "Selling the Department of Energy's Depleted Uranium Stockpile: Opportunities and Challenges"

March 12, 2008

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, "Regulatory Failure: Must America Live with Unsafe Food?"

February 26, 2008

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing titled, "Contaminated Food: Private Sector Accountability"

February 12, 2008

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled, "Ketek Clinical Study Fraud: What Aventis Knew"

January 29, 2008

Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing entitled, "Science and Mission at Risk: FDA's Self-Assessment"

January 23, 2008

Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing entitled, "Combating Nuclear Proliferation: The Effectiveness of the Department of Energy's Initiatives for Proliferation Prevention (IPP) Program"

December 12, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing entitled, "Energy Speculation: Is Greater Regulation Needed to Stop Price Manipulation?"

December 11, 2007

Dingell, Stupak on HHS Agreement on Food and Drug Safety Imports

Nov. 13, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing Entitled "Diminshed Capacity: Can the FDA Assure the Safety and Security of the Nation's Food Supply? - Part IV - Deception in Labeling"

Nov. 1, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing Entitled, "FDA Foreign Drug Inspection Program: A System At Risk"

Oct. 24, 2007

Chairman Dingell, Subcommittee on Oversight and Investigations Hearing entitled “NASPER: Why Has the National All Schedules Prescription Electronic Reporting Act Not Been Implemented?”

Oct. 11, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing entitled "Diminished Capacity: Can the FDA Assure the Safety and Security of the Nation's Food Supply? - Part III"

Oct. 4, 2007

Chairman Dingell, Subcommittee on Oversight and Investigations hearing entitled "Germs, Viruses, and Secrets: The Silent Proliferation of Bio-Research Laboratories in the United States"

Sept. 18, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing Entitled "Nuclear Terrorism Prevention: Status Report on the Federal Government's Assessment of New Radiation Detection Monitors"

Aug. 1 , 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing Entitled "Post-Katrina Health Care in the New Orleans Region: Progress and Continuing Concerns - Part II"

July 17, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "Diminished Capacity: Can the FDA Assure the Safety and Security of the Nation's Food Supply? - Part 2"

June 26, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "Predatory Sales Practices in Medicare Advantage"

June 12, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "Poisoned Patriots: Contaminated Drinking Water at Camp Lejeune"

May 22, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations Hearing on "Gasoline Prices, Oil Company Profits, and the American Consumer"

May 16, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "2006 Prudhoe Bay Shutdown: Will Recent Regulatory Changes and BP Management Reforms Prevent Future Failures?"

April 24, 2007

Statement of the Honorable John D. Dingell at the Subcommittee on Oversight and Investigations hearing entitled "Diminished Capacity: Can the FDA Assure the Safety and Security of the Nation's Food Supply?"

April 20, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "The Department of Energy's Response to Ongoing Mismanagement at the Los Alamos National Labs"

March 22, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "The Adequacy of the FDA Efforts to Assure the Safety of the Drug Supply Part II"

March 13, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "Post Katrina Health Care: Continuing Concerns and Immediate Needs in the New Orleans Region"

February 13, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "The Adequacy of FDA Efforts to Assure the Safety of the Drug Supply"

January 30, 2007

Chairman Dingell at the Subcommittee on Oversight and Investigations hearing entitled "Continuing Security Concerns at Los Alamos National Laboratory"

 

Reports

December 13, 2006

 

October 25, 2006

Department of Health and Human Services Inspector General -- Vulnerabilities in Departmental Issuance of Conflict of Interest Waivers

Department of Health and Human Services Inspector General -- Former CMS Administrator Thomas A. Scully's May 2003 waiver under Section 208(b)

(See also Committee letters of October 21, 2004 and December 22, 2003)

Note: If you would like to view materials released by other Members of the Committee, click here to link to their home pages.

To read these documents, you must have Adobe Acrobat Reader software installed on your computer. Click on the icon below to download this software for free if you do not have it already installed.